Erratum to: Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.

Erratum to: Malar J (2015) 14:310 DOI 10.1186/s12936-015-0824-y

The authors of the original article [1] have recently noticed that the published paper contained some errors.

In Table 2, ‘Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)’, the column “IR (interval risk)” should have read “CSP (cumulative survival probability)”. Table 2 is correctly displayed in this erratum.

Table 2

Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)

Days	Subjects at risk	Lost to follow up	Therapeutic failure	CSP	CITF
0	125	0	0	1.00	0
2	125	0	0	1.00	0
3	125	0	1	0.99	0.01
7	124	3	0	0.99	0.01
14	121	0	0	0.99	0.01
21	121	0	0	0.99	0.01
28	121	0	0	0.99	0.01

CSP cumulative survival probability, CITF cumulative incidence of therapeutic failure

Further, in the first paragraph of the ‘Discussion’ section, another case report should have been mentioned in the final sentence, to read as follows: “Nonetheless, of the published literature from India, only two case reports dating back over two decades confirms CQ failure in P. vivax despite having adequate plasma concentration of CQ [17,18].”

A new Reference 18 [2] should have been included and the subsequent references renumbered to 19–26.